Emerging Immunotargets and Immunotherapies in Prostate Cancer.
Montironi R, Santoni M, Sotte V, Cheng L, Lopez-Beltran A, Massari F, Matrana MR, Moch H, Berardi R, Scarpelli M.
Montironi R, et al. Among authors: cheng l.
Curr Drug Targets. 2016;17(7):777-82. doi: 10.2174/1389450117666160217123304.
Curr Drug Targets. 2016.
PMID: 26898309
Review.